Mounjaro (Tirzepatide) 5mg/0.5ml Injection in Kenya

Mounjaro (Tirzepatide) 5mg/0.5ml Injection in Kenya

KSh 75,000.00

Mounjaro (Tirzepatide) 5mg/0.5ml Injection in Kenya is a prescription medication designed to support blood sugar control in adults with type 2 diabetes. It is a once-weekly injection that works by activating receptors involved in insulin regulation and appetite control, helping patients manage glucose levels, weight, and overall metabolic health.

Mounjaro (Tirzepatide) 5mg/0.5ml Injection in Kenya

KSh 75,000.00

Add to cart
Buy Now


Mounjaro (Tirzepatide) 5mg/0.5ml Injection in Kenya is a prescription medication designed to support blood sugar control in adults with type 2 diabetes. It is a once-weekly injection that works by activating receptors involved in insulin regulation and appetite control, helping patients manage glucose levels, weight, and overall metabolic health.

Key Benefits:

  • Supports Blood Sugar Control – Helps regulate glucose in type 2 diabetes.

  • Once-Weekly Dose – Convenient injection schedule.

  • Weight Management – May assist in reducing appetite and body weight.

  • Advanced Dual-Action Therapy – Targets both GIP and GLP-1 receptors.

  • Doctor-Recommended – Backed by clinical research for safety and efficacy.

Product Details:

  • Brand: Mounjaro (Tirzepatide)

  • Strength: 5mg/0.5ml per vial

  • Form: Solution for Injection

  • Usage: Subcutaneous injection, once weekly

  • Packaging: 1 single-use vial

Suggested Use:
Administer one injection weekly as prescribed by a healthcare professional. Rotate injection sites (abdomen, thigh, or upper arm).

Caution:

  • For prescription use only.

  • Not suitable for individuals with type 1 diabetes.

  • Consult your doctor if pregnant, breastfeeding, or on other diabetes medications.

  • Possible side effects include nausea, diarrhea, or reduced appetite.

Reviews

There are no reviews yet.

Be the first to review “Mounjaro (Tirzepatide) 5mg/0.5ml Injection in Kenya”

Your email address will not be published. Required fields are marked *

Top